Prevention of Cardiovascular Disease in Women: Highlights for the Clinician of the 2011 American Heart Association Guidelines

被引:8
|
作者
Wenger, Nanette K. [1 ]
机构
[1] Emory Univ, Sch Med, Emory Heart & Vasc Ctr, Atlanta, GA 30303 USA
关键词
Prevention; Cardiovascular disease; Women; AHA guidelines; VITAMIN-E; PREGNANCY; HEALTH; RISK; DYSFUNCTION; MANAGEMENT; EVENTS; HYPERTENSION; KNOWLEDGE; ASPIRIN;
D O I
10.1053/j.ackd.2013.02.006
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The 2011 Update to the American Heart Association Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women is designed to assist women and health professionals in understanding the cardiovascular disease risk for women and undertaking the most effective preventive interventions. Although coronary heart disease remains the leading cause of mortality for women in the United States, cardiovascular mortality among U.S. women has decreased dramatically each year since 2000, with the decline in mortality being steeper for women than for men. Nonetheless, since 1984, more women than men continue to die annually from cardiovascular disease. Half of the decrement in cardiovascular mortality for women since 2000 reflects the improved management of their established cardiovascular disease; the other half is attributable to reductions in their major coronary risk factors, hence the importance of this prevention guideline. (c) 2013 by the National Kidney Foundation, Inc. All rights reserved.
引用
收藏
页码:419 / 422
页数:4
相关论文
共 50 条